Constrictive pericarditis secondary prevention: Difference between revisions
Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures for the secondary pr..." |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Constrictive pericarditis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
Revision as of 20:16, 10 December 2019
Constrictive Pericarditis Microchapters |
Differentiating Constrictive Pericarditis from other Diseases |
---|
Treatment |
Case Studies |
Constrictive pericarditis secondary prevention On the Web |
American Roentgen Ray Society Images of Constrictive pericarditis secondary prevention |
Risk calculators and risk factors for Constrictive pericarditis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]